Fig 26 - by Piotr Popik (292215)

Fig 26 - by Zhezhe Zhang (19704587)

Interleaved increasing (uneven numbered tones) and decreasing (even numbered tones) series of tones, ISI 26.6ms. by Nathanael Larigaldie (21703267)

Loss of RBM-26 causes mitochondria dysfunction in PLM. by Tamjid A. Chowdhury (14149846)

Subjects:

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

Subjects:

Loss of RBM-26 function causes a reduction in the density of mitochondria in the PLM axon. by Tamjid A. Chowdhury (14149846)

Subjects:

Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Subjects:

Radiation patterns at1.9 GHz, 2.1 GHz, 2.6 GHz, and 3.5 GHz. by Wen-Ying Zhou (10049543)

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

Subjects:

Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

Subjects:

Histogram of number of drugs with (a) increased and (b) decreased usage within 12 months. by Nguyen Thach (20347852)

CD26 and CD68 are not specific markers for DCs or macrophages. by Bianca Pellegrino (20314999)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. by Tamjid A. Chowdhury (14149846)

Subjects:

Temperature field considering the insulation layer deterioration (2.6 °C). by Jianqing Jia (21001506)

Minimum principal stress considering the insulation layer deterioration (2.6 °C). by Jianqing Jia (21001506)

Temperature field without considering insulation layer deterioration (2.6 °C). by Jianqing Jia (21001506)

Maximum temperature and freeze-thaw thickness of surrounding rock (2.6 °C). by Jianqing Jia (21001506)

Studies measuring provider-level impact (N = 26, 81% of included studies). by Emily M. Jones (21989800)

Study Flow Diagram. by Elizabeth S. Munroe (21568166)